EvokAI Creative Labs Inc. (TSXV:OKAI) entered into a definitive agreement to acquire NeuroCarrier Oy on May 16, 2023. Completion of the NeuroCarrier Acquisition is subject to a number of standard conditions, including receipt of all regulatory approvals and the acceptance of the TSX Venture Exchange (?TSXV?). The NeuroCarrier Acquisition is expected to close in June, 2023. Pursuant to the terms of the Share Purchase Agreement, holders of 100% of NeuroCarriers? common shares (?NeuroCarrier Shares?) will be issued 2,202,000 common shares of the Company (the ?Shares?) having an aggregate value of ?3,000,000, as consideration in exchange for their NeuroCarrier Shares. The Shares issued will be subject to an agreed hold period ending 1 year from the date of issuance. Up to an additional 367,000 common shares of the Company may be issuable to the current holders of NeuroCarrier Shares upon NeuroCarrier achieving certain milestones on or before November 16, 2023.

EvokAI Creative Labs Inc. (TSXV:OKAI) completed the acquisition of NeuroCarrier Oy on June 15, 2023.